NCT05985928

Brief Summary

Researchers will investigate the correlation between a) self-reported dietary intake of foods and beverages, b) intensity of sucrose stimuli, and c) liking rating of sweet stimuli, with the relative expression of the taste receptor genes from human fungiform papillae (TAS1R2 and TAS1R3). \* This research will provide new information on how sweet taste perception is regulated.

  • The hypothesis: Greater dietary consumption of sugar and sweet foods is associated with reduced expression of the sweet taste receptors.
  • The results of this study could help to identify pathways to help modify sweet taste perception by uncovering this mechanism. Participants will sample solutions prepared with sweet ingredients, provide salivary DNA, and collect fungiform papillae. This will allow researchers and investigators to compare the relationship between the sweetness of stimuli, genetic differences in sweet taste receptors, and expression levels of sweet taste receptor genes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2025

Completed
Last Updated

August 5, 2025

Status Verified

May 1, 2023

Enrollment Period

2.1 years

First QC Date

July 13, 2023

Last Update Submit

July 30, 2025

Conditions

Keywords

sweetgeneticsgene expressiondietary intakepsychophysics

Outcome Measures

Primary Outcomes (4)

  • Gene expression and sweet taste perception

    The relative level of gene expression of sweet taste receptors (TAS1R2 and TAS1R3) and relationship with sweet taste perception (gLMS ratings of sampled sucrose)

    Day 1 (single time-point)

  • Gene expression and sweet taste liking

    The relative level of gene expression of sweet taste receptors (TAS1R2 and TAS1R3) and relationship with sweet taste perception (hedonic ratings of sampled sucrose)

    Day 1 (single time-point)

  • Gene expression and dietary intake

    The relative gene level expression of sweet taste receptors and relationship with self-reported dietary intake of sweet foods and beverages

    Day 1 (single time-point)

  • Gene expression and sweet liker status

    The relative gene level expression of sweet taste receptors and relationship with the self-reported liking of a variety of sweet foods and beverages

    Day 1 (single time-point)

Secondary Outcomes (3)

  • Genetics and sweet taste perception

    Day 1 (single time-point)

  • Genetics and sweet taste liking

    Day 1 (single time-point)

  • Genetics and sweet liker status

    Day 1 (single time-point)

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy adults, over the age of 18, able to provide consent in English, able to complete survey on an electronic device

You may qualify if:

  • between 18 and 45 years old,
  • have no tongue or cheek piercings,
  • not a user of tobacco products or electronic cigarettes (within the last year),
  • no known defects in taste or smell,
  • not pregnant or breastfeeding,
  • no history of chronic pain in the mouth,
  • not taking any prescription pain medication,
  • not taking any blood thinners,
  • no history of cancer or cancer treatment,
  • not diabetic or restricting intake of sugars for medical reasons, under the direction of a physician or healthcare provider
  • willing to undergo the Fungiform Papillae biopsy procedure
  • willing to provide salivary DNA
  • Not currently experiencing any COVID-19 symptoms
  • Not recently diagnosed (in the last 30 days) with COVID-19
  • No history of high blood pressure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts

Amherst, Massachusetts, 01003, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

saliva, tissue

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2023

First Posted

August 14, 2023

Study Start

March 20, 2023

Primary Completion

April 20, 2025

Study Completion

May 20, 2025

Last Updated

August 5, 2025

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

Data will be shared at the request, after signing release form. No PHI will be included. All data will be de-identified. Data and meta-data will be shared, along with code books.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available following publication of results.
Access Criteria
Individuals can access the following signing form from IRB.

Locations